CRL

#3612
Charles River Laboratories International, Inc. Common Stock
1.8 1 USD
-99.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
1.81
1.84
Year Range
1.60
228.88
Daily Change
-99.00%
Monthly Change
-98.90%
6 month change
-98.98%
Year Change
-99.08%
Previous Close
181.4 1
Open
1.8 3
Low
1.8 1
High
1.8 4
Volume
662
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 87.04 M
  • Employee 20 K
  • Founded N/A
  • CEO James C. Foster
  • Website www.criver.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000BG5BL8
  • Industry Diagnostics & Research
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-43.05
Price to sales ratio
1.96

Charles River Laboratories International, Inc. Common Stock

Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients. Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs. As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL.

News